Invesco Ltd. - CRINETICS PHARMACEUTICALS IN ownership

CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 139 filers reported holding CRINETICS PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 19.18 and the average weighting 0.3%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of CRINETICS PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$5,275,073
+679.0%
177,373
+372.0%
0.00%
Q2 2023$677,138
+9.8%
37,577
-2.2%
0.00%
Q1 2023$616,865
+84.4%
38,410
+110.1%
0.00%
Q4 2022$334,543
-8.6%
18,281
-2.0%
0.00%
Q3 2022$366,000
-6.2%
18,647
-10.9%
0.00%
Q2 2022$390,000
-8.2%
20,919
+8.1%
0.00%
Q1 2022$425,000
-92.1%
19,343
-89.8%
0.00%
-100.0%
Q4 2021$5,404,000
+1457.3%
190,235
+1052.9%
0.00%
Q3 2021$347,000
+34.5%
16,501
+20.4%
0.00%
Q2 2021$258,00013,7020.00%
Other shareholders
CRINETICS PHARMACEUTICALS IN shareholders Q2 2023
NameSharesValueWeighting ↓
Vivo Capital, LLC 3,375,169$84,379,0007.91%
RA Capital Management 1,875,209$46,880,0002.52%
Perceptive Advisors 2,587,953$64,698,0001.48%
New Leaf Venture Partners, L.L.C. 167,700$4,193,0001.12%
Orbimed Advisors 2,039,282$50,982,0000.79%
Eventide Asset Management 803,839$20,096,0000.61%
Novo Holdings A/S 135,009$3,375,0000.47%
Opaleye Management Inc. 36,000$900,0000.27%
ADAGE CAPITAL PARTNERS GP, L.L.C. 490,000$12,250,0000.03%
Baker Brothers Advisors 132,985$3,325,0000.02%
View complete list of CRINETICS PHARMACEUTICALS IN shareholders